Sensory gating deficits in schizophrenia: can we parse the effects of medication, nicotine use, and changes in clinical status?

被引:39
作者
Light, GA [1 ]
Braff, DL [1 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
关键词
schizophrenia; suppression; gating; P50; potential suppression and prepulse inhibition; medications effects;
D O I
10.1016/S1566-2772(03)00018-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Schizophrenia is a disorder characterized by core deficits in information processing and attentional mechanisms. Abnormalities in the neural substrates associated with the filtering or 'gating' of sensory information are among the most consistent findings in schizophrenia research. Intact gating and inhibitory mechanisms are necessary in order to navigate successfully in a stimulus-laden world, and to selectively attend to salient stimuli and ignore redundant, repetitive, or trivial information. An individual's gating functioning can be assessed via self-report measures and/or using laboratory-based psychophysiological paradigms such as P50 event-related potential suppression and prepulse inhibition (PPI). In this paper, the literature on gating deficits across the schizophrenia spectrum and the reported effects of nicotine and medications on P50 suppression and PPI is reviewed. In addition, productive strategies for 'parsing' specific medication effects on P50 suppression and PPI deficits and directions for future research that would enable us to answer residual questions about the functional correlates of these abnormalities in schizophrenia patients are discussed. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 106 条
[1]   Schizophrenia, sensory gating, and nicotinic receptors [J].
Adler, LE ;
Olincy, A ;
Waldo, M ;
Harris, JG ;
Griffith, J ;
Stevens, K ;
Flach, K ;
Nagamoto, H ;
Bickford, P ;
Leonard, S ;
Freedman, R .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202
[2]  
ADLER LE, 1982, BIOL PSYCHIAT, V17, P639
[3]   NORMALIZATION BY NICOTINE OF DEFICIENT AUDITORY SENSORY GATING IN THE RELATIVES OF SCHIZOPHRENICS [J].
ADLER, LE ;
HOFFER, LJ ;
GRIFFITH, J ;
WALDO, MC ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1992, 32 (07) :607-616
[4]  
ADLER LE, 1993, AM J PSYCHIAT, V150, P1856
[5]   Elementary phenotypes in the neurobiological and genetic study of schizophrenia [J].
Adler, LE ;
Freedman, R ;
Ross, RG ;
Olincy, A ;
Waldo, MC .
BIOLOGICAL PSYCHIATRY, 1999, 46 (01) :8-18
[6]  
Adler LE, 1999, BIOL PSYCHIAT, V45, p35S
[7]   SENSORY PHYSIOLOGY AND CATECHOLAMINES IN SCHIZOPHRENIA AND MANIA [J].
ADLER, LE ;
GERHARDT, GA ;
FRANKS, R ;
BAKER, N ;
NAGAMOTO, H ;
DREBING, C ;
FREEDMAN, R .
PSYCHIATRY RESEARCH, 1990, 31 (03) :297-309
[8]  
AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826
[9]  
Arango C, 1999, AM J PSYCHIAT, V156, P1097
[10]   NEUROPHYSIOLOGICAL ASSESSMENT OF SENSORY GATING IN PSYCHIATRIC-INPATIENTS - COMPARISON BETWEEN SCHIZOPHRENIA AND OTHER DIAGNOSES [J].
BAKER, N ;
ADLER, LE ;
FRANKS, RD ;
WALDO, M ;
BERRY, S ;
NAGAMOTO, H ;
MUCKLE, A ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1987, 22 (05) :603-617